weightloss.com.au
weightloss.com.au
Contrave logoContrave
vs
Wegovy logoWegovy

Contrave vs Wegovy

Contrave is a daily oral tablet at $150-200/month that targets brain reward pathways for ~5-8% weight loss. Wegovy is a weekly semaglutide injection at $350-460/month that produces ~15-17% weight loss with proven cardiovascular benefit. Contrave is the more affordable option for those who prefer tablets over injections.

Contrave: ~5-8% avg. loss
Wegovy: ~15-17% avg. loss
Contrave cost: $150-200 private
Wegovy cost: $350-460 private

Compare Contrave vs Wegovy at a Glance

 ContraveWegovy
Drug classOpioid antagonist + NDRI combinationGLP-1 receptor agonist
How takenDaily oral tabletsWeekly injection (oral pill in US only)
Avg. weight loss~5-8%~15-17%
First approved2014 (FDA), 2019 (TGA)2021 (FDA), 2024 (TGA)
AU cost/month$150-200 private$350-460 private
PBS statusNoPending (Jan 2026 rec.)
Prescription needed?YesYes
AU supply statusNo issuesStable

Compare Contrave vs Wegovy Cost in Australia

Contrave: $150-200 private

Wegovy: $350-460 private (PBS: Pending (Jan 2026 rec.))

Compare Contrave vs Wegovy Weight Loss Efficacy

Contrave Clinical Trials

COR-I

6.1% weight loss vs 1.3% placebo

56 weeksn=1,742

COR-II

6.4% weight loss maintained

56 weeks

COR-BMOD

9.3% with intensive behaviour modification

56 weeks

Wegovy Clinical Trials

STEP 1

14.9% weight loss vs 2.4% placebo

68 weeksn=1,961

STEP UP (7.2mg)

21% weight loss

72 weeks

SELECT

20% reduction in CV events

4+ yearsn=17,604

OASIS-4 (pill)

16.6% weight loss (oral form)

64 weeks

Clinical trial data at highest approved doses. Individual results vary.

Compare Contrave vs Wegovy Side Effects

Contrave

Very common

  • Nausea (32%)
  • Constipation (18%)
  • Headache (14%)

Common

  • Vomiting
  • Dizziness
  • Insomnia
  • Dry mouth
  • Diarrhoea

Serious (rare)

  • Seizures (contraindicated in seizure disorders)
  • Increased blood pressure
  • Hepatotoxicity
  • Suicidal thoughts (bupropion, young adults)
  • Cannot be used with opioids

Wegovy

Very common

  • Nausea (up to 44%)
  • Diarrhoea
  • Vomiting
  • Constipation

Common

  • Headache
  • Abdominal pain
  • Fatigue
  • Dyspepsia
  • Injection site reactions

Serious (rare)

  • Pancreatitis
  • Gallbladder disease
  • Acute kidney injury
  • Suicidal ideation (under investigation)
  • Potential fracture risk (Dec 2025 warning)

Compare How Contrave and Wegovy Work

Contrave

Opioid antagonist + NDRI combination

Targets two brain pathways. Naltrexone (opioid antagonist) blocks reward/craving pathways in the mesolimbic dopamine circuit. Bupropion (NDRI) acts on the hypothalamic appetite centre to reduce hunger. The combination addresses both biological hunger drive and reward-based food cravings.

Wegovy

GLP-1 receptor agonist

Same mechanism as Ozempic but at higher dose (2.4mg vs 1mg) optimised for weight management. Mimics GLP-1 hormone, reducing appetite, slowing gastric emptying, and improving satiety. The oral pill (US only) uses SNAC technology to protect the molecule in the stomach.

Compare Contrave vs Wegovy Dosing Schedule

Contrave

Daily oral tablets

DosePeriodNote
1 tab morningWeek 1Starting dose
1 AM + 1 PMWeek 2Escalation
2 AM + 1 PMWeek 3Escalation
2 AM + 2 PMWeek 4+Maintenance (4 tablets/day)

Wegovy

Weekly injection (oral pill in US only)

DosePeriodNote
0.25mgWeeks 1-4Starting dose
0.5mgWeeks 5-8Escalation
1mgWeeks 9-12Escalation
1.7mgWeeks 13-16Escalation
2.4mgWeek 17+Maintenance dose

Compare Contrave vs Wegovy Australian Regulatory Status

Contrave

TGA StatusRegistered on ARTG for chronic weight management
PBS ListedNo PBS listing
Supply StatusNo supply issues
Key AdvantageOnly combination oral weight loss drug in AU; no injections needed
UK NameMarketed as Mysimba in the UK

Wegovy

TGA StatusRegistered on ARTG for chronic weight management and CV risk reduction
PBS ListedPBAC recommended Jan 2026; price negotiation underway
PBS CriteriaBMI ≥35 (≥32.5 for Asian, Aboriginal, Torres Strait Islander) + established CVD
Supply StatusMore stable supply than Ozempic as of early 2026
Oral PillNot available in Australia. Launched in US Jan 2026.

Full Contrave profile

View Contrave Details

Full Wegovy profile

View Wegovy Details

Compare Other Medications

View all weight loss medications

This website is for informational and research purposes only. We are not medical professionals and nothing on this page constitutes medical advice, diagnosis, or treatment. Always consult a qualified doctor or specialist before making any decisions about medication.

The weight loss medication landscape in Australia is changing rapidly. Information on this page may become outdated without notice. Data sourced from the TGA, FDA, MHRA, NICE, PBAC, Australian Prescriber, Obesity Evidence Hub, and clinical trial publications. Last reviewed March 2026.